Unknown

Dataset Information

0

The impact of concordant and discordant conditions on the quality of care for hyperlipidemia.


ABSTRACT:

Background

Physician treatment of cardiovascular risk factors may be affected by specific types of patient comorbidities.

Objectives

To examine the relationship between discordant comorbidities and LDL-cholesterol management in hypertensive patients not previously treated with lipid-lowering therapy; to determine whether the presence of cardiovascular (concordant) conditions mediates this relationship.

Design

We performed a retrospective cohort study of 1,935 hypertensive primary care patients (men >45 years of age, women >55 years of age) with documented elevated low-density lipoprotein (LDL) cholesterol and no lipid-lowering therapy at baseline. The outcome was guideline-consistent hyperlipidemia management defined as optimal value on repeat LDL cholesterol testing or initiation of lipid-lowering therapy. Using generalized estimating equations (GEE), we examined the association of concordant and discordant comorbidities with guideline-consistent hyperlipidemia management over a 2-year follow-up period, adjusting for patient characteristics.

Results

Guideline-consistent hyperlipidemia management was achieved in 1,236 patients (64%). In the fully adjusted model, each additional discordant condition resulted in a 19% lower adjusted odds ratio of guideline-consistent hyperlipidemia management (p < 0.001) when compared with no discordant conditions. The dampening effect of discordant conditions on guideline-consistent management persisted even in the presence of concordant conditions, but each additional concordant condition was associated with a 37% increase in the adjusted odds of guideline-consistent hyperlipidemia management (p < 0.001).

Conclusions

In this cohort of hypertensive primary care patients, the number of conditions discordant with cardiovascular risk was strongly negatively associated with guideline-consistent hyperlipidemia management even in patients at the highest risk for cardiovascular events and cardiac death.

SUBMITTER: Lagu T 

PROVIDER: S-EPMC2517982 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4333015 | biostudies-literature
| S-EPMC2257994 | biostudies-other
| S-EPMC2427204 | biostudies-literature
| S-EPMC3589381 | biostudies-literature
| S-EPMC6028011 | biostudies-literature
| S-EPMC5509775 | biostudies-literature
| S-EPMC4527112 | biostudies-literature
| S-EPMC5421639 | biostudies-literature
| S-EPMC3390356 | biostudies-literature
| S-EPMC5608750 | biostudies-literature